WO2014019042A1 - Conjunto de tampa dotada com conexão para acoplamento de seringa hipodérmica e sobretampa para emprego no fechamento de frascos destinados ao envase de produtos farmacêuticos e medicamentos injetáveis - Google Patents
Conjunto de tampa dotada com conexão para acoplamento de seringa hipodérmica e sobretampa para emprego no fechamento de frascos destinados ao envase de produtos farmacêuticos e medicamentos injetáveis Download PDFInfo
- Publication number
- WO2014019042A1 WO2014019042A1 PCT/BR2013/000273 BR2013000273W WO2014019042A1 WO 2014019042 A1 WO2014019042 A1 WO 2014019042A1 BR 2013000273 W BR2013000273 W BR 2013000273W WO 2014019042 A1 WO2014019042 A1 WO 2014019042A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lid
- overcap
- assembly
- connection
- cap
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
- A61J1/1418—Threaded type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
- A61J1/1481—Inlet or outlet ports with connection retaining means, e.g. thread or snap-fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
- A61J1/1425—Snap-fit type
Definitions
- This disclosure describes a patent which proposes a cap provided with a connection for coupling a hypodermic syringe, said cap having a corresponding overcap.
- the cap and overcap assembly treated herein is intended to be a viable alternative to the stoppers normally intended for use in the closure of vials serving as a medicine filling medium, notably for vials intended for filling pharmaceutical and injectable medicines.
- the inventor of this new kind of medium for closure of drug filling bottles, notably pharmaceutical and injectable drug bottles, has been researching, for the past seven years, the subjects related to injectable products, and from these researches conclusions have been reached about some aspects of the utmost importance that were amenable to improvement.
- the second patent application originated from the research carried out by the present inventor is PI 1003460-9, which deals with a new diluent pouch or liquid injectable medicament.
- PI 1003460-9 Among the many innovative features that characterize the type of pouch proposed in PI 1003460-9 are: the possibility of direct coupling of a hypodermic syringe without the use of a needle, the possibility of direct coupling of a vial of the type used for the filling of pharmaceuticals and injectables, provision of sealing inlet / outlet connections and means to allow repeated opening / closing cycles and also dose fractionation, filtering means to prevent rubber particles ("Coring") from the perforation of conventional stoppers by the use of needles or "Spike” (plastic needle) are introduced into the internal environment of the bag and can be improperly administered to the patient.
- Coring rubber particles
- Spike plastic needle
- closure used to provide closure of the vials
- closure is commonly defined as a stopper.
- a stopper which is used to produce the closure of vials that serve as a filling medium for injectable drugs, seeking a design solution that allows obtaining a new and original closure medium, which, unlike conventional stoppers can be defined as " No Coring Stopper ", hence the name of the new closure as” No coring stopper "(a closure in the form of a cap and its overcap applicable on vials for pharmaceuticals and injectables).
- this closing means can be considered as non-particle generating).
- an ideal closure means for injectable drug vials should, among other things, ensure: complete sealing of the vial; ensure the maintenance of sterility of the product; be easy and safe to use and do not generate particles when reconstituting and removing the product from the vial.
- the new closure proposed by this patent application is embodied in an innovative cap and its corresponding overcap, both made of plastic polymer (several polymers already studied are compatible with injectable drugs, as we said), incorporates a connection that configures a Diluent injection port and needle-free removal of the product and, as it has an external locking edge that mechanically engages the contouring edge normally incorporated into the bottle mouth, avoids the process of placing an aluminum seal for recapping the stopper .
- An end product for parenteral use should be liquid. So this powder in vial of Glass is a product that requires a final manufacturing step to recover the form required for injectable use, the liquid form.
- stoppers are traditionally made of natural or synthetic rubber, contain leachable components (which may detach and contaminate the products with which they come in contact), are sterilizable only externally by autoclaving and / or radiation and yet (be leachable and contain non-sterile internal particles), will be transfixed by a metal needle or spikes (plastic needles) generating particles. Therefore, the final manufacturing process (reconstitution) of a parenteral product cannot be completed today without a high chance of contamination and / or particle generation, in addition to the possibility of puncture accident, thus contradicting the Good Practice precepts. Pharmaceutical Manufacturing.
- the new closure embodied as a plastic cap (and its respective overcap), treated here attaches to the bottle by screwing it by its outer upper edge, has central connection with "negative luer” terminal and overcap with "positive luer” .
- the overcap is pre-fixed to the lid and sealed by a plastic seal (breakable weld line) that will be broken only when the product is used.
- This cover and overcap assembly can be assembled in three ways: a) for products not lyophilized, the protective cap (overcap) is already previously sealed by a plastic seal to the cap, which will be broken only at the moment of free access to the product; b) for lyophilized products, the protective cap (overcap) is only soldered to the cap after the lyophilization process, because the lyophilization process requires keeping an open point on the cap for sublimation (for escape of steam formed by direct stage transition).
- a variant assembly for lyophilized products provides the same cap with the overcap affixed and sealed, but with a central cone protruding into the bottle, flush with the wall and with a series of rounded openings through which steam will flow in the lyophilization process, before the total closure of the bottle.
- a "luer” device has been placed in the center of the lid for direct connection to the syringes or a special luer terminal diluent pouch design with an open mechanism. e-closes, as proposed in patent application PI 1003460-9.
- the new cover (and its overcap) is part of the manufacturing process without requiring complex changes to today's sterile filling machines (eg the Zanasi MD-300), but only requires slight adjustments to the feeder trays. Filling machines (without tamper with the main structure of the machine).
- a plastic welder for the protective cap will only be used when the cap treated here has to be employed for the closure of vials containing lyophilized products. If in this case an option is made to mount the cap, where it already incorporates the affixed and sealed overcap and which has a central cone with openings for steam passage, the plastic welder is eliminated in the process of filling lyophilized injectables.
- the flask may also (as long as the product allows direct contact with the diluent) attach directly to the diluent bag (treated in PI 1003460-9), also provided with a luer terminal and appropriate open-close mechanism. one real closed drug reconstitution and dilution system.
- the new cap treated here dispensing needles for reconstitution procedures (remember that one needle is usually used for reconstitution and another for administration), saves the reconstitution process by using fewer needles, reducing the preparation time for injecting medicines and also for preventing puncture accidents.
- the GIFT COVER SET WITH CONNECTION FOR HYDODERMIC SYRINGE MATCHING AND SURGEAGE FOR EMPLOYMENT OF BOTTLES FOR INJECTABLE PHARMACEUTICAL PRODUCTS AND MEDICINAL PRODUCTS is as follows: a) unlike conventional stoppers that are produced in rubber it is made of plastic polymer (several already validated for pharmaceutical use);
- (b) has a central negative luer terminal and a central positive luer overcap
- the product may be aspirated into the syringe, transferred to a diluent pouch, or a luer terminal pouch (pouch treated in PI 1003460-9) to avoid the use of needle) ;
- g allows for easy fractionation of the dose without particle generation (no rubber to be suffocated), solving an eternal problem particularly of pediatrics;
- h) provides savings by not using needles and above all by substantially increasing the speed of the (i) process of preparation of injectable products; and j) eliminates the possibility of puncture accident as no needles are used.
- Figure 1 illustrates a perspective view of the main lid model shown herein
- Figure 2 illustrates a sectional view taken along the section line "A" - "A” shown in Figure 1;
- Fig. 2A is an enlarged detail taken from Fig. 2, as indicated by arrow X, which relates to the joining or sealing region that is produced between the lid and its overcap;
- Figure 3 illustrates a view of the cap shown herein being suitably mounted on a generic vial model of the type commonly used for filling pharmaceutical or injectable products;
- Figure 4 illustrates a sectional overview of the vial and the cap treated herein, which section is taken along the "B" - “B” section line shown in Figure 3;
- Figure 5 schematically illustrates the direction of rotation should be employed to produce the separation between the overcap and the cap that remains firmly attached to the bottle; in the present figure the direction of rotation is indicated by the counterclockwise "A"arrows;
- Fig. 6 illustrates a schematic section based on the condition initially depicted in Fig. 5, where the overcap is removed while the cap remains firmly mounted on the vial nozzle; in this figure the arrows indicating the direction of rotation for overcap removal follow that in figure 5 and are referred to as arrows "A", while arrow "B" indicates the direction of overcap distance from the lid;
- Figure 7 schematically illustrates the possibility of direct coupling between a hypodermic syringe (not equipped with its needle) and the cap mounted next to the vial, said figure indicating that the reconstitution liquid contained within the syringe is being inside the vial as shown by the arrow "D" which represents the direction of advance of the syringe plunger and also the arrows "E” which represent the direction of flow of the reconstitution liquid upon exiting the syringe and also upon entering the syringe. bottle;
- Figure 8 illustrates the subsequent stage to that depicted in Figure 7 and where the reconstitution liquid has already been properly homogenized to the product (originally in powder form) which was packaged in the vial;
- This figure depicts the aspiration of the reconstituted product into the hypodermic syringe as seen by the arrow "F” representing the plunger retraction movement and also the arrows "G” indicating the flow direction of the syringe. reconstituted product as it passes into the syringe;
- FIG. 9 schematically depicts the possibility of direct coupling between a syringe and a pouch as proposed in patent application PI 1003460-9;
- This figure while not portraying the material actually claimed in this patent application, serves to demonstrate the dynamics of preparation of pharmaceutical substances and / or injectable products that was made possible, in previous stages, by the use of the cap now proposed as a form of closure of the vial. as illustrated in figures 7 and 8; the present figure includes arrows "H" representing the inflow of reconstituted product that is administered to the pouch;
- FIG. 9 shows, in schematic form, the possibility of direct coupling between a bottle fitted with the lid assembly patent and a pouch such as that proposed in patent application PI 1003460-9; said figure 9A depicts this possibility of direct coupling, which is useful in cases where reconstitution and dilution of the drug may be performed with the same diluent;
- Figure 10 illustrates an embodiment of the closure treated herein when it is intended to be used for closure of vials containing lyophilized pharmaceuticals or injectables;
- the cap can be initially fixed to the bottle without being equipped with its corresponding overcap;
- Figure 11 illustrates, also schematically, the stage at which the liquid-filled flask to be subjected to the lyophilization process loses, by sublimation, vapor from its liquid phase; In this condition the overcap should be away from the cap so that the generated vapors can find a quick exit route out of the bottle as indicated by the arrows "I";
- Figure 12 illustrates, also schematically, the condition of mounting the overcap against its respective cap, thus ensuring airtight closure of the bottle; in the present figure the clockwise direction of rotation that produces the Overcap is represented by the arrows "J”, while the resulting approaching movement between the overcap and the lid is indicated by the arrow "K"; a plastic welder will fix the overcap to the lid;
- Figure 13 illustrates a first variant of the now treated lid which is specifically prepared for use with liquid products which need to be lyophilized
- Fig. 14 illustrates a total section taken from Fig. 13 as indicated by the "C” - “C” section line, thereby demonstrating the inner portion of said first variant
- Fig. 15 illustrates the closure produced in the first embodiment and which is intended for closure of vials containing pharmaceutical or liquid injectable products which are to be lyophilized;
- the cap can initially be introduced into the mouth of the bottle to a level that clears the vapors outlet holes;
- Figure 16 illustrates, also schematically, the stage at which the liquid-filled flask to be subjected to the lyophilization process loses, by sublimation, vapor from its liquid phase; in this condition the vapors exit the interior of the vial through the holes in the central portion of the lid which provide a quick exit route as indicated by arrows "I";
- Figure 17 illustrates, also schematically, the completion condition of the assembly of the first cap variant treated herein against the neck of the vial; in the present figure the approach movement between the cap as a whole and the bottle neck is indicated by the arrow "K";
- Figure 18 illustrates a second variant of the cap proposed herein, which has a different configuration with respect to the overcap and employs, as a feature of reinforcing cap closure to the bottle, a crimping seal, which may preferably be obtained by the use of plastics material;
- Fig. 19 shows a section taken from the lid embodied as a second variant, said section being taken along the "D" - “D” section line of Fig. 18;
- Figure 20 illustrates a schematic sectional view of a third embodiment of the lid treated herein, which includes a central projection in its lower region, serving as a facilitating guide for fixing the lid;
- 21 illustrates a fourth variant of the proposed cap, which is derived from the embodiment of FIGS. 18 and 19; includes a central projection, as verified and described in the model of figure 20; 21A illustrates a schematic detail depicting the contact form between the central projection integrating the cap and the inner wall of the bottle neck against which the cap is applied;
- Fig. 22 illustrates a fifth cap variant, which is the subject of this patent application, which is derived from the cap model of Figs. 18 and 19 and includes a central projection in its lower region suitable for use in vials to be used. bottled with liquid products that require a lyophilization process;
- Fig. 23 illustrates a sixth variant of the cap treated herein, which is derived from the embodiment of Fig. 22 and includes a differentiated system for fixing the overcap to the cap itself, which system employs mutual retaining ribs between the cap and overcap ;
- Figure 24 illustrates a seventh variant of the lid that is the subject of this patent application, which is a variation of the lid design of Figure 23 with respect to its overcap, but includes a central projection serving as a facilitating guide for securing the lid. lid, in its lower region for use in bottles intended for filling products which do not need to be lyophilized;
- Fig. 25 illustrates an eighth variant of the cap object of this patent application, which includes a reduced diameter overcap and cap fastening system in the molds of the model shown in Fig. 23 and has a recess ring as proposed in models of figures 18 and 19 and 21 and 22;
- Fig. 26 illustrates a ninth variant of the cap treated herein which combines a differently designed overcap which is joined to its cap by a crimping ring which may be made of plastic;
- Fig. 27 illustrates a section taken from Fig. 26 as indicated by the section line " ⁇ " - ⁇ ⁇ "of Fig. 26.
- the lid assembly 100 includes a lid itself which is indicated by the numeral reference 1, which is complemented by an overcap 2, a piece made of plastic polymer obtained by injection molding and which is formed by a disc-shaped section 3 which is complemented by a vertical contouring wall 4, the latter being provided inferiorly in its inner region by a thickened and inwardly curved edge 5.
- the circumference of the circular face of the disc-shaped section 3 of cap 1 has a prominent upward edge 8 that ends at a sharp edge 9, while the bottom face 10 of the disc-shaped section 3 rests on the mouth F1 of the disc. vial F.
- the lid assembly in its major version 100 further has an overcap 2 which, as with respect to lid 1, is also made of plastic polymer and injection molding process.
- the overcap 2 has a disc shape having a contour wall 11, preferably sized to have the same diameter measurement as the lid 1.
- the bottom edge of the contour wall 11 ends at a sharp edge 12 identical to the edge 9 incorporated into the lid 1.
- the central and lower region of overcap 2 has a tubular projection 13 also on the luer pattern and having an inner thread 13 ', which complements and connects to the luer fitting 6 via the thread 7 which is part of the cap 1.
- the tubular projection 13 is centrally and coaxially positioned a cylindrical projection 13A which enters the tubular fitting 6 of cap 1.
- Edges 9 and 12 of cap 1 and overcap 2 are made so that they are facing each other and can be joined by welding S, as shown in Figure 2A, and that welding line S constitutes the region or break line R to be effectively broken at the time of separation of overcap 2 from cover 1.
- the main model 100 of the cap and overcap assembly proposed herein may be mounted on a generic vial model F, as may initially be seen in FIGS. 3 to 8, such assembly being such that the underside 10 of the cap 1 contact the upper edge of the mouth F of the vial F, while the thickened and bent inward edge 5 establishes a locking condition with the contouring edge F2 of said vial F, as can be understood through the observation of figures 4, 6, 7 and 8.
- the lid assembly 100 constituting the main model of;
- the lid treated herein is made so that it can be mounted against the bottle F by compression effect, the retention being generated by the thickened and curved edge 5 of the lid 1 and the contouring edge F2 from bottle F.
- cap 1 and its overcap 2
- cap 1 and its overcap 2
- the overcap 2 should be rotated as indicated by the arrows "A” in figure 6 while being detached from cap 1 as indicated by the arrow "B” of the same figure 6, which operation requires the rupture of the rupture line R previously established by the weld S of the edges 9 and 12.
- the luer fitting 6 of cap 1 allows the procedure shown in Figure 7 to occur, where a SH hypodermic syringe is used to directly insert into the bottle F a given volume of liquid L for reconstitution. of the powdered medicine M that is contained inside vial F.
- Figure 7 depicts the advancing movement of the SH syringe plunger SH1 so that the reconstitution liquid L contained therein can be transferred into the vial F as indicated by the arrows "E".
- connection between the SH syringe and the vial. F is made possible precisely by the fact that the SH syringe also conventionally has a connection of the same "luer" pattern as provided for in cap 1.
- Figure 7 schematically depicts the possibility of direct coupling between an SH hypodermic syringe (not equipped with its needle) and the cap 1 of the assembly 100 which is mounted next to the vial F.
- FIG 8 illustrates the stage subsequent to that depicted in Figure 7 and where the reconstitution liquid L has already been properly homogenized to drug M which was stored in vial F;
- This figure depicts the aspiration of the product (reconstituted drug M) into the SH hypodermic syringe as seen by the arrow "F” representing the retraction movement of the SH syringe plunger SH1 and also the arrows "G” which indicate the flow direction of the reconstituted product (reconstituted drug M) as it passes into the SH syringe.
- Figure 9 serves to demonstrate the dynamics of preparation of pharmaceutical substances and / or injectables that was made possible in earlier stages by the use of the cap assembly 1 conjunto0 (cap and overcap) proposed herein.
- the arrows "H” represent the inlet flow of the reconstituted product (reconstituted medicament M) which is delivered to pouch B through its inlet port BI which also has a luer pattern terminal.
- the lid proposed here also allows its direct connection to a copy of pouch B with pattern "luer" in cases where the reconstitution and dilution of the drug can be performed with the same diluent, which means that in this case it is performed. single operation, ie reconstitution and dilution.
- Figure 9A depicts exactly the condition that a pouch B of the kind described in patent application PI 1003460-9 can be directly coupled through its inlet port Bl which has a respective connection in the "luer” pattern, the connection "luer” of cap 1 mounted on vial F.
- the cap assembly shown is indicated by reference 100, which does not preclude the condition that the same type of direct connection can be established with any of the other versions of the cover assembly in question.
- Figures 10, 11 and 12 illustrate the cap assembly 100 treated herein in a condition in which it is employed with vials F to be filled with liquid medicaments which will undergo a lyophilization process.
- figure 10 depicts an early stage, where drug M still in its liquid phase is already packaged inside vial F and where vial F is already equipped with cap 1 still separate from its overcap 2.
- Figure 11 shows schematically what happens at the moment of the effective lyophilization step, where drug M loses, by sublimation (evaporation), its liquid phase, as indicated by arrows I, remaining inside vial F only drug M in its powdery state.
- Figure 12 depicts the stage following that shown in Figure 11, where upon complete evaporation of the liquid phase of drug M contained in vial F, cap 1 which closes vial F receives its overcap 2 which is screwed onto cap 1 via the luer terminals.
- Arrows "J” show the clockwise direction of rotation required to mount overcap 2 next to cover 1, while arrow “K” indicates the approach direction between overcap 2 and lid 1.
- FIGS 10, 11 and 12 give a schematic picture of the fact that the lid assembly 100, by providing that the lid 1 and its overcap 2 may be initially separated and may then be joined together, in short, by welding S, allows its use for the closure of vials that contain liquid medicines M that must undergo a lyophilization process.
- Figure 13 illustrates a first variant of the lid now treated which as a whole is indicated by reference 110.
- the lid assembly 110 treated herein and which is depicted in FIGS. 13, 14, 15, 16 and 17 is a version intended particularly for use in vials F that have to be filled with liquid medicaments which will undergo a lyophilization process.
- the assembly 110 unlike that found with respect to the assembly 100 depicted in figures 10, 11 and 12, does not require its overcap 2 to be separated from the lid 1 at the time of performing the lyophilization step.
- the lid 1 has a central projection 14 having a slightly tapered lower end 15, while the upper portion of that central projection 14 incorporates equidistantly disposed through holes 16.
- overcap 2 does not differ from the set 100 model, as in This is true of cover 1, the only exception being the provision of the aforementioned central projection 14.
- Assembly 110 has the same basic details as regards lid 1 and overcap 2, which are found in assembly 100.
- the assembly 110 as with respect to the assembly 100 has its cover 1 formed by a disc-shaped section 3 which is complemented by a vertical contouring wall 4, the latter being provided inferiorly in its inner region by an edge thickened and curved inwards 5.
- the circumference of the circular face of the disc-shaped section 3 of cap 1 has a prominent upward edge 8 that ends at a sharp edge 9, while the bottom face 10 of the disc-shaped section 3 rests on the mouth of the bottle. .
- the details described above are also particularly given in figure 14.
- the overcap 2 of the assembly 110 has a disc shape having a contour wall 11, preferably preferably of the same diameter as the lid 1.
- the middle and lower region of the overcap 2 of the assembly 110 has a tubular projection 13 also in the luer "6 pattern and featuring an internal 13 ' thread which complements and connects to the" luer "connection 6 through the thread. 7 forming part of the cap 1.
- the tubular projection 13 has centrally and coaxially positioned a cylindrical projection 13A, which enters the tubular connection 6 of the cap 1.
- edges 9 and 12 of the lid 1 and overcap 2 are provided, which are produced so that they can be joined by welding S and when joined define the breaking line R.
- the central projection 14 of the assembly 110 makes all the difference in that it allows it to be preliminarily mounted on the vial F, as shown in Fig. 15, in a condition that coincides with the through holes 16 disposed above the upper edge of the vial. flask mouth F.
- the powdered drug M may be definitively closed within vial F through lowering of the assembly 110 as shown in figure 17 and as indicated by the arrow K.
- the assembly 110 When lowered under pressure, the assembly 110 establishes with retainer F a retention condition with respect to its cap 1, as with respect to the assembly 100, whereby the through holes 16 are then blocked. by the neck wall F3 of the bottle F. When the assembly 110 is lowered the locking of the thickened edge 5 of the lid 1 against the contouring edge F2 of the bottle F. is established.
- FIGs 15, 16 and 17 show that the lid assembly 110 is complete from the initial stage depicted in figure 15, or in other words, the lid assembly 110 may have its lid 1 and its respective overcap 2 previously joined together. finally by welding, being applied in this condition to flask F and maintaining this condition even after the completion of its coupling with flask F, as specifically depicted in figure 17.
- Figure 16 clearly and clearly demonstrates the fact that the vapor comes from the sublimation of the phase. of drug M finds in the through-holes 16 a quick exit route as indicated by the arrows "I".
- Figure 18 illustrates a second variant of the cover proposed herein which, as a whole, is indicated by reference 120 and has a different configuration with respect to overcap 2 and employs, as a means of tightening the lid 1 to the vial F, a crimping seal 17.
- Overcap 2 of cover assembly 120 differs from overcap 2 used in sets 100 and 110 only in that it has a relatively small diameter.
- Reducing the diameter of the overcap 2 has the function of allowing the recess seal 17, which can be made of plastic, to advance with its upper edge 18 over the upper wall of the disc-shaped section 3 of the lid 1.
- Cover 1 of assembly 120 differs from the model adopted in assemblies 100 and 110 in that its edge 9 has a reduced diameter arrangement to the same extent as edge 12 of overcap 2.
- the use of the recess seal 17 in the lid assembly 120 is intended to increase the connection between the lid 1 (and hence also its overcap 2) with the vial F (not shown in figures 18 and 19), mainly because the seal
- the bottom edge 19 reinforces, with its lower edge 19, the actuation of the thickened curved edge 5 which integrates the lid structure 1 over the edge F2 of the vial F.
- the assembly 120 has the same basic details in the which cover its cover 1 and overcap 2 and are also found in assembly 100.
- Lid 1 of assembly 120 is formed by a disc-shaped section 3 which is complemented by a vertical contour wall 4, the latter being undercut by a thickened and inwardly curved edge 5, the center of which is the circular face of the section.
- a vertical tubular connection 6 made in the "luer" pattern is formed vertically upwards and has a thread 7 on its outer wall.
- the circumference of the circular face of the disc-shaped section 3 of the lid 1 has a prominent upward edge 8 that ends at the aforementioned sharp edge 9, while the bottom face 10 of the disc-shaped section 3 rests on the mouth of the disc. bottle.
- the overcap 2 of the assembly 120 as verified with respect to the assembly 100, has a disk shape having a contour wall 11 sized to have, as already explained, a smaller diameter measurement than that found in the lid 1.
- the central and lower region of overcap 2 of assembly 120 has a tubular projection 13 also in the "luer” pattern having an internal thread 13 ' , which complements and connects to the "luer” connection 6 through the thread 7 1.
- the tubular projection 13 has centrally and coaxially positioned a cylindrical projection 13A which enters the tubular connection 6 of the cap 1.
- the edges 9 and 12, when welded together S define the breaking line R.
- Figure 20 illustrates a schematic sectional view of a third variant of the lid treated herein which is indicated as a whole by reference 130.
- Set 130 is basically a sub-variant of set 100, differing from the latter in that it includes a central projection 20 in its lower region, central projection 20 having a slightly conical lower end 21, as found with central projection 14 adopted as a whole 110.
- the central projection 20 serves as a facilitating guide for attaching cap 1 to mouth F / neck F2 of bottle F (bottle F is not specifically depicted in Figure 20).
- Set 130 has the same basic details as its cover 1 and overcap 2 as found in set 100.
- the lid 1 of the assembly 130 is formed by a disc shaped section 3 which is complemented by a vertical contour wall 4, the latter being undercut by a thickened and inwardly curved edge 5, the center of which is the circular face of the section. in a disk shape 3 part, vertically upwards, a tubular connection 6 elaborated in the "luer" pattern, and which on its outer wall has a wire external thread 7.
- the circumference of the circular face of the disc-shaped section 3 of cap 1 has a prominent upward edge 8 that ends at a sharp edge 9, while the bottom face 10 of the disc-shaped section 3 rests on the mouth of the bottle. .
- the overcap 2 of assembly 130 as verified with respect to assembly 100, has a disk shape having a contour wall 11 sized to have a diameter measurement equal to that found in cap 1.
- the middle and lower region of overcap 2 of assembly 130 has a tubular projection 13 also in the "luer” pattern having an inner thread 13 ', which complements and connects to the "luer” fitting 6 via thread 7 which is part of the cap 1.
- the tubular projection 13 has centrally and coaxially positioned a cylindrical projection 13A, which enters the tubular connection 6 of the cap 1.
- the lid assembly 140 includes a lid 1 and its respective overcap 2, with overcap 2 having the same configuration of diameter adopted by the lid 2 used in the set 120, also adopting the recess seal 17.
- Lid 1 of assembly 140 has a version of central projection 20 adopted in assembly 130 which differs from this in that it further includes a contour rib 22 disposed on the outer region of central projection 20 to establish sealing connection with a contour recess. normally provided in the inner region of neck F3 of vial F.
- the provision of the contouring rib 22 in the central projection 20 has the function of raising both the retention condition of cap 1 relative to vial F by coupling said rib 22 against a recess.
- FIG. 21A which is an enlarged schematic detail taken from Fig. 21, includes a representation of the neck section F3 of a typical vial F and where the coupling between the rib 22 of the projection 20 and the recess F4 of the neck F3 of the vial F be viewed.
- Set 140 has the same basic details regarding its cover 1 and overcap 2 as are found in set 100.
- the lid 1 of the assembly 140 is formed by a disc-shaped section 3 which is complemented by a vertical contour wall 4, the latter being undercut by a thickened and curved inward edge 5, the center of which is the circular face of the section. in a disk shape 3 part, vertically upwards, a tubular connection 6 elaborated in the "luer" pattern, and which on its outer wall has a wire external thread 7.
- the circumference of the circular face of the disc-shaped section 3 of cap 1 has a prominent upward edge 8 that ends at a sharp edge 9, while the bottom face 10 of the disc-shaped section 3 rests on the mouth of the bottle. .
- the overcap 2 of the assembly 140 has a disc shape having a contour wall 11 sized to have a smaller diameter than the one in cap 1.
- the central and lower region of overcap 2 of assembly 140 has a tubular projection 13 also in the "luer” pattern with an internal 13 'thread which complements and connects to the "luer” connection 6 through the thread 7 which is part of the cap 1.
- the tubular projection 13 has centrally and coaxially positioned a cylindrical projection 13A, which enters the tubular connection 6 of the cap 1.
- Edges 9 and 12 when welded together, together define the breaking line R.
- Fig. 22 illustrates a fifth variant of the lid object of this patent application which as a whole is indicated by the numeral reference 150.
- the assembly 150 is derived from the lid design of the assembly 140 and includes a central projection in the molds of the present embodiment. in set 110 and which is indicated by reference 14, which is provided with a slightly tapered lower end 15, while the upper portion of that central projection 14 incorporates equidistantly disposed through holes 16.
- the central projection 14 further has a contouring rib 22 which has the function of elevating the retention condition of the cap 1 with respect to the vial F by coupling said rib 22 against the annular recess F4 provided on the inner wall of the neck F3 of the caps. commonly used vials F as already illustrated with respect to that depicted in figure 21A.
- Set 150 has the same basic details regarding its cover 1 and overcap 2 as are found in set 100.
- the lid 1 of the assembly 150 is formed by a disc-shaped section 3 which is complemented by a vertical contour wall 4, the latter being undercut by a thickened and inwardly curved edge 5, the center of which is the circular face of the section.
- a vertical luer tubular connection 6 is formed vertically upwards and has an external thread 7 on its outer wall.
- the circumference of the circular face of the disc-shaped section 3 of cap 1 has a prominent upward edge 8 that ends at a sharp edge 9, while the bottom face 10 of the disc-shaped section 3 rests on the mouth of the bottle. .
- Overcap 2 of assembly 150 as verified with respect to assembly 100, It has a disk shape having a contour wall 11 sized to have a smaller diameter than the one in lid 1.
- the middle and lower region of the overcap 2 of the assembly 150 has a tubular projection 13 also in the "luer” pattern and featuring an inert thread 13 ' , which complements and connects to the "luer” connection 6 through the thread. 7 forming part of the cap 1.
- the tubular projection 13 has centrally and coaxially positioned a cylindrical projection 13A which enters the tubular connection 6 of the cap 1.
- the assembly 150 is complemented by a recess seal 17. Edges 9 and 12 , when welded together, together define the breaking line R.
- Fig. 23 illustrates a sixth variant of the lid treated herein which as a whole is indicated by reference 160 and is derived from the embodiment of the assembly 150 shown in Fig. 22.
- Variant 160 includes a lid 1 which around its connection "Luer” 6 incorporates a smaller, low diameter contouring wall 23 provided with an outer contouring rib 24, against which an inner contouring rib 25 of a larger diameter contouring wall 26 is offset from the underside of the overcap 2.
- the overcap 2 of the assembly 160 further maintains the cylindrical projection 13A from its center which is sized to be inserted into the luer fitting 6 of the lid 1.
- contour walls 23 and 26 are an alternative to ensure mounting overcap 2 against cap 1 without the need for threads.
- Lid 1 of assembly 160 is provided with a central projection 14 having a slightly tapered lower end 15, while the upper portion of that central projection 14 incorporates equidistant through holes 16.
- Set 160 has the same basic details regarding its cover 1 and overcap 2 as are found in set 100.
- the lid 1 of the assembly 160 is formed by a disc-shaped section 3 which is complemented by a vertical contour wall 4, the latter being undercut by a thickened and inwardly curved edge 5.
- the circumference of the circular face of the disc-shaped section 3 of cap 1 has a prominent upward edge 8 that ends at a sharp edge 9, while the bottom face 10 of the disc-shaped section 3 rests on the mouth of the bottle. .
- the overcap 2 of the assembly 160 as verified with respect to the assembly 100, has a disk shape having a contour wall 11 sized to have a diameter measurement equal to that found in the lid 1.
- edges 9 and 12 when soldered together, together define. the line of disruption R.
- Fig. 24 illustrates a seventh variant of the lid object of this patent application which as a whole is indicated by reference 170.
- the assembly 170 is a variation of the lid design of the assembly 160 which differs from the latter assembly by It includes the central projection 20, which serves as a facilitating guide for cap fixation, for use in F bottles for filling products that do not need to be lyophilized.
- cap 1 has around its luer connection 6 a low, contoured wall 23 of smaller diameter provided with an outer contour rib 24 against which it is matched. an inner contour rib 25 of a larger diameter contour wall 26 which departs from the underside of overcap 2.
- the lid 1 of assembly 170 further maintains the cylindrical projection 13A which departs from its center and is sized to be inserted into the interior. luer fitting 6 of cover 1.
- contour walls 23 and 26 incorporated in cover 1 and overcap 2 of assembly 170, as found with respect to assembly 160, provide an alternative to ensuring mounting of overcap 2 against cover 1 without the need for threads.
- Set 170 has the same basic details as its cover 1 and overcap 2 and are found in set 100.
- Lid 1 of assembly 170 is formed by a disc-shaped section 3 which is complemented by a vertical contour wall 4, the latter being undercut by a thickened and inwardly curved edge 5.
- the circumference of the circular face of the disc-shaped section 3 of cap 1 has a prominent upward edge 8 that ends at a sharp edge 9, while the bottom face 10 of the disc-shaped section 3 rests on the mouth of the disc. bottle.
- the overcap 2 of the assembly 170 has a disk shape having a contour wall 11 sized to have a diameter measurement equal to that found on the lid 1.
- edges 9 and 12 when welded together, together define the breaking line R.
- FIG 25 illustrates an eighth variant of the lid object of this patent application, which as a whole is indicated by the reference numeral 180.
- the assembly 180 includes the lid arrangement 1, as found in the assembly 160, but in addition to that thereof. this arrangement employs a recess seal 17, whereby the overcap 2 has a reduced diameter arrangement, as for example in the assembly 150.
- the lid assembly 180 also includes a central projection 20, analogous to that seen in the assembly 140 pictured in Fig. 21, and that central projection 20 is also provided with a contour rib 22.
- the overcap fastening system 2 against the lid 1 follows the same.
- contour walls 23 and 26 incorporated into cover 1 and overcap 2 of assembly 180 provide an alternative to ensure that overcap 2 is mounted against cover 1 without the need for threads.
- Set 180 has the same basic details with respect to its cover 1 and overcap 2 as are found in set 100.
- the lid 1 of the assembly 180 is formed by a disc-shaped section 3 which is complemented by a vertical contour wall 4, the latter being undercut by a thickened and inwardly curved edge 5.
- the circumference of the circular face of the disc-shaped section 3 of cap 1 has a prominent upward edge 8 that ends at a sharp edge 9, while the bottom face 10 of the disc-shaped section 3 rests on the mouth of the bottle. .
- the overcap 2 of the assembly 180 has a disc shape having the aforementioned contour wall 11, but sized to have a smaller diameter measurement than that of the lid 1.
- the edges 9 and 12, when welded together, together define the break line R.
- Figures 26 and 27 illustrate a ninth variant of the cap proposed herein which, as a whole, is indicated by reference 190 and combines cap 1 of assembly 180 with an overcap mode 2 having a single discoid portion 27 which is retained by the upper edge 18 of the recess seal 17.
- Overcap 2 of assembly 190 has a smaller diameter portion 28, in the same molds as found, for example, in assembly 180 pictured in Figure 25.
- the recess seal 17 of assembly 190 has, in addition to ensuring that cap 1 is secured to the bottle, also has the function of attaching overcap 2 to the cap body 1.
- Lid 1 of assembly 190 It further maintains the cylindrical projection 13A from its center and which is sized to be inserted into the luer fitting 6 of the lid 1.
- Lid 1 of assembly 190 is formed by a disc shaped section 3 which is complemented by a vertical contour wall 4.
- the overcap 2 of the assembly 190 as verified with respect to the assembly 100, has a disc shape having the aforementioned contour wall 11, but sized to have a smaller diameter measurement than that found in the lid 1.
- the vertical contour wall 4 of lid 1 of assembly 190 is undercut by a thickened and inwardly bent edge 5.
- the break line R may be established at the time of overcap molding 2, so that the edges 9 and 12 are already produced in a fully bonded manner. It is worth mentioning that said break line R is exclusively positioned in overcap 2.
- the assembly 190 does not require the welding procedure of the joining region of the edges 9 and 12 of the lid 1 and overcap 2, since as an integral component, the overcap 2 is fixed to the lid 1 by the actuation of the crimping seal 17 , such overcap 2 should be positioned over the lid 1 prior to the execution of the crimping seal 17.
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13825146.7A EP2905009A4 (en) | 2012-08-02 | 2013-07-26 | STOPPING ASSEMBLY WITH A CONNECTION FOR COUPLING A HYPODERMIC SYRINGE AND A CAP FOR CLOSING BOTTLES FOR INJECTABLE PHARMACEUTICALS AND MEDICAMENTS |
JP2015524577A JP2015528726A (ja) | 2012-08-02 | 2013-07-26 | 注射用製剤及び医薬品の充填を目的とする容器を密封するために使用する皮下注射器接続用コネクターが備えられたキャップセット |
CA2884719A CA2884719A1 (en) | 2012-08-02 | 2013-07-26 | Stopper assembly with a connection for coupling a hypodermic syringe and with a cap, for closing bottles for injectable pharmaceuticals and medicinal drugs |
LU92416A LU92416B1 (fr) | 2012-08-02 | 2013-07-26 | Ensemble de bouchon doté de connexion pour accouplement de seringue hypodermique, et contre-bouchon à utiliser pour la fermature de flacons destinés au remplissage de produits pharmaceutiques et de médicaments injectables |
US14/419,093 US20150238387A1 (en) | 2012-08-02 | 2013-07-26 | Cap assembly having hypodermic syringe coupling connection and overcap for use in sealing of bottles filled with pharmaceutical and injectable medicine products |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRBR1020120193353 | 2012-08-02 | ||
BR102012019335A BR102012019335A2 (pt) | 2012-08-02 | 2012-08-02 | conjunto de tampa dotada com conexão para acoplamento de seringa hipodérmica,e sobretampa para emprego no fechamento de frascos destinados ao envase de produtos farmacêuticos e medicamentos injetáveis |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014019042A1 true WO2014019042A1 (pt) | 2014-02-06 |
Family
ID=50027001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BR2013/000273 WO2014019042A1 (pt) | 2012-08-02 | 2013-07-26 | Conjunto de tampa dotada com conexão para acoplamento de seringa hipodérmica e sobretampa para emprego no fechamento de frascos destinados ao envase de produtos farmacêuticos e medicamentos injetáveis |
Country Status (6)
Country | Link |
---|---|
US (1) | US20150238387A1 (pt) |
JP (1) | JP2015528726A (pt) |
BR (1) | BR102012019335A2 (pt) |
CA (1) | CA2884719A1 (pt) |
LU (1) | LU92416B1 (pt) |
WO (1) | WO2014019042A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2549694B9 (es) | 2014-10-23 | 2017-01-04 | Grifols, S.A. | Procedimiento de llenado aséptico de una bolsa |
EP3419582B1 (en) | 2016-02-24 | 2022-07-13 | Avent, Inc. | Fluid transfer connector |
CA3033748A1 (en) * | 2016-08-15 | 2018-02-22 | Genentech, Inc. | Vial assembly with luer fitting |
CN108088173B (zh) * | 2018-01-09 | 2023-06-02 | 连云港千樱医疗设备有限公司 | 一种口服液瓶的干燥方法及干燥机 |
JP1640356S (pt) * | 2018-08-22 | 2019-09-02 | ||
USD920108S1 (en) * | 2019-10-22 | 2021-05-25 | George J. Partsch, IV | Hygiene rinse cap |
US11903902B2 (en) | 2022-01-03 | 2024-02-20 | Benjamin Martin DAVIS | Fluid transfer couplings |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3817416A (en) * | 1972-08-02 | 1974-06-18 | A Costa | Safety closure cap for containers |
EP0829248A2 (en) * | 1996-09-13 | 1998-03-18 | Becton Dickinson France S.A. | A transfer assembly for a medicament container having a splashless valve |
US5902298A (en) * | 1997-11-07 | 1999-05-11 | Bracco Research Usa | Medicament container stopper with integral spike access means |
WO2002045473A2 (en) * | 2000-12-04 | 2002-06-13 | Cyclo-Fil Ltd. | Apparatus for the prevention of contamination in injection liquids |
US20080015539A1 (en) * | 2006-02-28 | 2008-01-17 | Robert Pieroni | Bottle with adapter for receiving needleless syringe |
WO2011039747A1 (en) * | 2009-10-01 | 2011-04-07 | Medimop Medical Projects Ltd | Vial assemblage with vial and pre-attached fluid transfer device |
BRPI1003460A2 (pt) | 2010-09-29 | 2013-01-22 | Norival Caetano | "bolsa para acondicionamento, reconstituiÇço e/ou diluiÇço de produtos de uso injetÁvel e dispositivo de seguranÇa aplicÁvel em frasco de medicamento a ser reconstituÍdo e/ou diluido em uma bolsa para acondicionamento, reconstituiÇço e/ou diluiÇço de produtos de uso injetÁvel" |
BRPI0822673A2 (pt) | 2008-08-15 | 2013-06-18 | Norival Caetano | padronizaÇço de medicamentos injetÁveis e seus diluentes |
-
2012
- 2012-08-02 BR BR102012019335A patent/BR102012019335A2/pt not_active IP Right Cessation
-
2013
- 2013-07-26 CA CA2884719A patent/CA2884719A1/en not_active Abandoned
- 2013-07-26 US US14/419,093 patent/US20150238387A1/en not_active Abandoned
- 2013-07-26 JP JP2015524577A patent/JP2015528726A/ja active Pending
- 2013-07-26 WO PCT/BR2013/000273 patent/WO2014019042A1/pt active Application Filing
- 2013-07-26 LU LU92416A patent/LU92416B1/fr active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3817416A (en) * | 1972-08-02 | 1974-06-18 | A Costa | Safety closure cap for containers |
EP0829248A2 (en) * | 1996-09-13 | 1998-03-18 | Becton Dickinson France S.A. | A transfer assembly for a medicament container having a splashless valve |
US5902298A (en) * | 1997-11-07 | 1999-05-11 | Bracco Research Usa | Medicament container stopper with integral spike access means |
WO2002045473A2 (en) * | 2000-12-04 | 2002-06-13 | Cyclo-Fil Ltd. | Apparatus for the prevention of contamination in injection liquids |
US20080015539A1 (en) * | 2006-02-28 | 2008-01-17 | Robert Pieroni | Bottle with adapter for receiving needleless syringe |
BRPI0822673A2 (pt) | 2008-08-15 | 2013-06-18 | Norival Caetano | padronizaÇço de medicamentos injetÁveis e seus diluentes |
WO2011039747A1 (en) * | 2009-10-01 | 2011-04-07 | Medimop Medical Projects Ltd | Vial assemblage with vial and pre-attached fluid transfer device |
BRPI1003460A2 (pt) | 2010-09-29 | 2013-01-22 | Norival Caetano | "bolsa para acondicionamento, reconstituiÇço e/ou diluiÇço de produtos de uso injetÁvel e dispositivo de seguranÇa aplicÁvel em frasco de medicamento a ser reconstituÍdo e/ou diluido em uma bolsa para acondicionamento, reconstituiÇço e/ou diluiÇço de produtos de uso injetÁvel" |
Also Published As
Publication number | Publication date |
---|---|
BR102012019335A2 (pt) | 2016-02-02 |
CA2884719A1 (en) | 2014-02-06 |
US20150238387A1 (en) | 2015-08-27 |
JP2015528726A (ja) | 2015-10-01 |
LU92416B1 (fr) | 2014-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014019042A1 (pt) | Conjunto de tampa dotada com conexão para acoplamento de seringa hipodérmica e sobretampa para emprego no fechamento de frascos destinados ao envase de produtos farmacêuticos e medicamentos injetáveis | |
US10898659B1 (en) | System for handling and dispensing a plurality of products | |
AU743521B2 (en) | A container closure with a frangible seal and a connector for a fluid transfer device | |
JP6628152B2 (ja) | ボトルの密閉方法および関連する密閉されたボトル | |
CA2677286C (en) | Closure cap for a container for receiving medical liquids, and container for receiving medical liquids | |
US11224555B2 (en) | Access and vapor containment system for a drug vial and method of making and using same | |
JP6310855B2 (ja) | パッケージ | |
ES2535533T3 (es) | Cápsula de plástico y método de producción de la misma | |
JP2009528866A (ja) | 医療用バイアル | |
JPH09104460A (ja) | 再シール可能な膜アセンブリを有するバイアル | |
JP2008001430A (ja) | 無菌製品のフラスコ用の栓及び無菌計量充填における当該栓の使用 | |
EA020842B1 (ru) | Укупорочный колпачок для емкостей, предназначенных для помещения медицинских жидкостей, и емкость для помещения медицинских жидкостей | |
JP2011530377A (ja) | 薬剤容器システムにおいて使用される2つ以上の成分の混合のための容器用充てん済みインサート | |
US11697527B1 (en) | Tamper evident closure assembly | |
JP2014534125A (ja) | パッケージ | |
ITMI20132005A1 (it) | Complesso di chiusura per flacone, relativo flacone e metodo di assemblaggio | |
AU2012266372A1 (en) | Stopping device and container comprising such a device | |
JP2019508326A (ja) | 取付け具を備えたパウチおよびパウチを作製する方法 | |
WO2012040799A1 (pt) | Conector tipo spike para bolsa de reconstituição de medicamento e dispositivo de segurança para frasco de medicamento a ser reconstituído | |
US20080027382A1 (en) | Device for handling perfusion liquids | |
RU173333U1 (ru) | Крышка для укупорки полимерных флаконов с инфузионными медицинскими растворами | |
EP2905009A1 (en) | Stopper assembly with a connection for coupling a hypodermic syringe and with a cap, for closing bottles for injectable pharmaceuticals and medicinal drugs | |
BR112019010889A2 (pt) | produto de recipiente de plástico | |
US20220040040A1 (en) | Valve with on-off mechanism for bag used for conditioning, reconstituting and/or diluting of injectable products | |
KR20240072553A (ko) | 의료용 봉인스티커 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13825146 Country of ref document: EP Kind code of ref document: A1 |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2884719 Country of ref document: CA Ref document number: 2015524577 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14419093 Country of ref document: US |
|
REEP | Request for entry into the european phase |
Ref document number: 2013825146 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013825146 Country of ref document: EP |